lock icon
Positive scientific opinion from the European Medicines Agency for MSD’s oral antiviral therapy in development against COVID-19

Save Print

24.11.2021 08:00 Europe/Zurich

This message is password-protected and is intended exclusively for media representatives.

Please enter the password.

Media representatives can request the login data here: media.switzerland@msd.com

Do you have a question or need more information? Here you will find the right media contact.